about
Phytoestrogen biomonitoring: an extractionless LC-MS/MS method for measuring urinary isoflavones and lignans by use of atmospheric pressure photoionization (APPI).Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteriaDietary lignans: physiology and potential for cardiovascular disease risk reduction.In vitro microbiotic fermentation causes an extensive metabolite turnover of rye bran phytochemicals.In vitro transformation of chlorogenic acid by human gut microbiota.Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United StatesGut metabolites and bacterial community networks during a pilot intervention study with flaxseeds in healthy adult men.Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system.Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors.Role of phytoestrogens in cancer therapy.Association between Dietary Share of Ultra-Processed Foods and Urinary Concentrations of Phytoestrogens in the US.The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept.Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.Dietary fibers and associated phytochemicals in cereals.Absorption of plant lignans from cereals in an experimental pig model.Use of antibiotics is associated with lower enterolactone plasma concentration.Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?Detection of novel metabolites of flaxseed lignans in vitro and in vivo.Soy, Soy Foods and Their Role in Vegetarian Diets.An altered tissue distribution of flaxseed lignans and their metabolites in Abcg2 knockout mice.Low serum enterolactone concentration is associated with low colonic Lactobacillus-Enterococcus counts in men but is not affected by a synbiotic mixture in a randomised, placebo-controlled, double-blind, cross-over intervention study.Exploring Effects of Chitosan Oligosaccharides on Mice Gut Microbiota in Fermentation and Animal ModelRole of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside
P2860
Q33452595-6AF6457D-64F7-49A5-A6B6-0FC79BA722FBQ33557801-23B9594B-6853-4FF2-BB97-CDD8683AA1EAQ34140938-80BC46E6-6F7B-4049-837A-B2E750D465EAQ34321319-B24978CB-8292-42B5-9FD1-622FA16BE7C4Q35097048-A7936DA8-1095-4A3B-AFD0-040A11794BCBQ35353462-7B073972-EDA5-491D-AD6E-BA3B336A67FFQ35635017-5C5C324A-29BF-4519-9379-5DEDF469A688Q36162933-32E7E372-5922-4F1C-9E47-5A461B9EE502Q36267739-AEA318A8-CBA3-4079-A7B3-4E1078685CA4Q37238391-A85CCA69-4E16-4B2C-A131-DB6EB7B8374FQ37729649-AE807ECA-CFD0-485B-A4F7-4938FEB1BAC1Q37848454-BBEC267C-E22F-4C72-B9EE-CE839AD5BA8AQ38624696-CBE03EC4-A006-4DCD-B5C9-56D943C399AFQ38998537-5EF61B84-F509-463A-99FF-752C24D0E97BQ39899989-E24EDCE1-7670-44D4-9C42-2505D6584930Q40631325-3931CF2A-41A8-46E0-A374-02605A066E48Q45072672-5C739BA9-2935-460A-800C-01E04B20413CQ46596459-2215A2F9-CFD4-4584-A394-05996F57BDE1Q47230001-45043D4E-4EF4-4FA8-B4A9-790BF0F6DD3CQ47239710-CD403929-4E69-4D78-BF99-A38CC5518ABAQ47846989-D5A25E91-2392-4B33-B439-DA5074FC6294Q57816741-5BD7AFB1-7422-4B9E-9029-62A073A8FB14Q58655903-E5D9CB78-DBB0-4CEF-852E-E92E86BE58F5
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Bioavailability of lignans in human subjects.
@ast
Bioavailability of lignans in human subjects.
@en
Bioavailability of lignans in human subjects.
@nl
type
label
Bioavailability of lignans in human subjects.
@ast
Bioavailability of lignans in human subjects.
@en
Bioavailability of lignans in human subjects.
@nl
prefLabel
Bioavailability of lignans in human subjects.
@ast
Bioavailability of lignans in human subjects.
@en
Bioavailability of lignans in human subjects.
@nl
P2093
P2860
P1476
Bioavailability of lignans in human subjects.
@en
P2093
Michael Blaut
Thomas Clavel
P2860
P304
P356
10.1017/S0954422407249704
P50
P577
2006-12-01T00:00:00Z